Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT03623373
Brief Title: Acalabrutinib With Alternating Cycles of Bendamustine / Rituximab and Cytarabine / Rituximab for Untreated Mantle Cell Lymphoma

First Submitted : July 26, 2018
First Submitted that Met QC Criteria : August 7, 2018
First Posted : August 9, 2018

Last Update Submitted that Met QC Criteria : January 3, 2019
Last Update Posted : January 4, 2019